Published in Probl Tuberk Bolezn Legk on January 01, 2008
[New microbiological Techniques in diagnosis of tuberculosis]. Probl Tuberk (1996) 1.13
[Artificial pneumoperitoneum in the complex treatment of pulmonary tuberculosis patients isolating drug-resistant mycobacterium tuberculosis]. Probl Tuberk Bolezn Legk (2006) 0.85
[Systemic transplantation of autologous mesenchymal stem cells of the bone marrow in the treatment of patients with multidrug-resistant pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.79
[Wide range of the use of natural lipases and esterases to inhibit Mycobacterium tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.78
[The effect of an epiphyseal extract on regulation of fat-carbohydrate metabolism]. Probl Endokrinol (Mosk) (1976) 0.76
[Clinical and laboratory evaluation of the efficiency of chronic hemodialysis treatment using acidosuccinate in patients with terminal renal failure]. Ter Arkh (2013) 0.76
[Inhibition of the transplacental blastomogenic effect of N-nitrosomethylurea in rats by buformin]. Biull Eksp Biol Med (1980) 0.76
[Quality of life and cognitive functions in patients with end-stage renal failure on hemodialysis using a succinate-containing dialyzing solution]. Ter Arkh (2014) 0.75
[Inhibitory Properties of Nitrogen-Containing Adamantane Derivatives with Monoterpenoid Fragments Against Tyrosyl-DNA Phosphodiesterase I]. Bioorg Khim (2016) 0.75
A peculiarity of the reaction of tRNA aminoacylation catalyzed by phenylalanyl-tRNA synthetase from the extreme thermophile Thermus thermophilus. Biochim Biophys Acta (1998) 0.75
Interferon status in children during acute respiratory infections. Therapy with interferon. Bull Exp Biol Med (2009) 0.75
[Role and significance of structural, metabolic and functional disorders of mononuclear phagocytes in pathogenesis of caseous pneumonia]. Probl Tuberk (1997) 0.75
[Somatomedin activity of the blood: hormonal metabolic and immunological shifts in cancer patients]. Vopr Onkol (1988) 0.75
[Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system]. Probl Tuberk Bolezn Legk (2006) 0.75
[Identification of tuberculosis pathogens in clinical material using the polymerase chain reaction]. Mol Gen Mikrobiol Virusol (1995) 0.75
[Role of lymphokines in immune response in respiratory viral infections]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.75
[Role of paramedical personnel in delivering obstetrical and gynecological care to workers in viscose production]. Feldsher Akush (1983) 0.75
[Diagnosis of tuberculous pericarditis in patients with HIV-infection]. Ter Arkh (2011) 0.75
[Effect of phenformin (dibotin) on the state of fat-carbohydrate metabolism and fetal weight in pregnant rats previously given alloxan]. Patol Fiziol Eksp Ter (1977) 0.75
[Psychogenic disorders in patients on hemodialysis treatment]. Ter Arkh (1992) 0.75
Changes in blood somatomedin activity with age and during the development of age pathology. Hum Physiol (1979) 0.75
[Binding function of the serum albumin in food toxinfections]. Vrach Delo (1986) 0.75
[Characteristics of the intellectual-memory function of patients treated by chronic hemodialysis]. Klin Med (Mosk) (1991) 0.75
[Hormonal status and the clinical course of ovarian cancer]. Akush Ginekol (Mosk) (1978) 0.75
[Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis]. Probl Tuberk (2002) 0.75
[Characteristics of personality of patients with chronic renal failure]. Klin Med (Mosk) (1989) 0.75
[Psychological characteristics and quality of life of patients with chronic kidney diseases]. Ter Arkh (2003) 0.75
[Blood serum somatomedin activity in children with bone tumors]. Vopr Onkol (1982) 0.75
[Mechanisms of psychological defense in patients treated by long-term hemodialysis]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75
[Somatomedin; biological characteristics and various clinical data on its content in humans under normal and pathological conditions]. Probl Endokrinol (Mosk) (1978) 0.75
[Identification of mycobacteria in sputum by determining antigens in the culture medium]. Probl Tuberk (1994) 0.75
[Use of a valvular bronchoblocker in the treatment of patients with destructive pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.75
[Use of native and lyophilized Loewenstein-Jensen's solid media in determining drug resistance on mycobacterium tuberculosis strains]. Probl Tuberk (1999) 0.75
[Characteristics of medulloblastoma in children under age of three years]. Zh Vopr Neirokhir Im N N Burdenko (2013) 0.75
[Improving the diagnosis of pathological processes in the endometrium]. Akush Ginekol (Mosk) (1985) 0.75
[Blood insulin level in patients with malignant tumors]. Vopr Onkol (1982) 0.75
[Analysis of lethal outcomes in patients with newly-diagnosed tuberculosis of the respiratory organs in combination with HIV-infection]. Ter Arkh (2011) 0.75
Postvaccinal changes in the nitric oxide system after immunization with live dry tularemia vaccine. Bull Exp Biol Med (2011) 0.75
[Cardinal problems of the regional bacteriological laboratories of tuberculosis facilities]. Probl Tuberk Bolezn Legk (2008) 0.75
[Quality of life of patients treated by hemodialysis]. Klin Med (Mosk) (1996) 0.75
[Efficacy of ofloxacin (zanocin) in the treatment of multidrug resistant pulmonary tuberculosis]. Antibiot Khimioter (2003) 0.75
[Determination of drug sensitivity of Mycobacterium tuberculosis on solid and liquid culture media]. Vestn Ross Akad Med Nauk (1995) 0.75
[Humoral immune response in humans and animals infected and immunized with Mycobacteria of the MAIS complex]. Probl Tuberk (1994) 0.75
[The ratio in the DNA content and protein mass of human cardiomyocytes]. Biull Eksp Biol Med (1988) 0.75
[Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection]. Probl Tuberk (1999) 0.75
[The characteristics of a Russian-made kit for the serological identification of streptococci groups A, B and C]. Zh Mikrobiol Epidemiol Immunobiol (1992) 0.75
[Reaction of the fetus in utero to the effect of factors of a chemical origin]. Pediatr Akus Ginekol (1977) 0.75
[To the optimization and evidence of current chemotherapy regimens for pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[Results of treatment of atypical endometrial hyperplasia]. Akush Ginekol (Mosk) (1987) 0.75
[Effect of small concentrations of carbon disulfide and hydrogen sulfide on the intrauterine development of rats]. Arkh Anat Gistol Embriol (1975) 0.75
[Effect of carbon disulfide on the cellular chromosome apparatus of rats and their fetuses]. Tsitol Genet (1982) 0.75
[Bacteremia in tuberculosis and other mycobacterial infections]. Probl Tuberk (1999) 0.75
[The dymanics of sex chromatin content in women with menstrual cycle disorders employed in the chemical industry]. Tsitol Genet (1975) 0.75
[Protein mass in human cardiomyocytes does not correspond to gene content]. Biull Eksp Biol Med (1991) 0.75
[Experimental study of the stability of expression of non-metrical threshold skeletal traits in inbred mice]. Genetika (1986) 0.75
[Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes]. Probl Tuberk Bolezn Legk (2004) 0.75
[Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance]. Probl Tuberk (2002) 0.75
[Dynamics of isolation of mycobacterium tuberculosis during 2-stage standard chemotherapy]. Probl Tuberk (1996) 0.75
[Frequency, pattern, and diagnosis of adverse reactions in patients with pulmonary tuberculosis during chemotherapy with leading drugs]. Probl Tuberk Bolezn Legk (2003) 0.75
[Pathogenesis of hyperplastic processes of the endometrium in the postmenopause]. Akush Ginekol (Mosk) (1987) 0.75
[The effect of Recormon therapy on the quality of life of patients on hemodialysis treatment]. Ter Arkh (1996) 0.75
[The state of specific functions in female workers subjected to exposure to epoxy resins and to epoxy resin-based polymeric materials during work activities (the data from a medical examination)]. Lik Sprava (1999) 0.75
[Evaluating regional system of occupational medical service organization]. Med Tr Prom Ekol (2011) 0.75
[Somatomedin activity in patients with malignant neoplasms]. Vopr Onkol (1988) 0.75
[Association of tuberculosis and primary lung cancer based on data of tuberculosis care facilities]. Probl Tuberk (1982) 0.75
[Biological properties of laboratory strains and clinical isolates of mycobacteria multiresistant to antitubercular preparations]. Probl Tuberk (1999) 0.75
[The factors affecting the rehabilitation of patients on chronic hemodialysis treatment]. Ter Arkh (1995) 0.75
[The ploidy variability of human cardiomyocytes]. Biull Eksp Biol Med (1989) 0.75
[S and R forms of Mycobacterium tuberculosis as a problem of producing cloned and phenotypically competent strains]. Probl Tuberk (1996) 0.75
[Capacity of rhabdomyosarcoma cells to produce substances with somatomedin and mitogenic activity]. Eksp Onkol (1988) 0.75
[Age-related changes in the carbohydrate and fat metabolic indices of female rats]. Probl Endokrinol (Mosk) (1981) 0.75
[Cellular technologies in therapy for chronic multidrug-resistant pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2006) 0.75
[Effect of carcinogenic 2-naphthylamine on organ cultures of the urinary bladder of the rat]. Vopr Onkol (1983) 0.75
[Chemotherapy of tuberculosis: problems and perspectives]. Vestn Ross Akad Med Nauk (2012) 0.75
[The psychosomatic aspects of patient adaptation to hemodialysis treatment]. Ter Arkh (1997) 0.75
[Quantitative determination of blood somatomedin activity]. Lab Delo (1980) 0.75
[Hormonal regulation of the somatomedin activity of the blood]. Probl Endokrinol (Mosk) (1981) 0.75
[Efficiency of preventive chemotherapy in children and adolescents from the bacterial isolation foci of tuberculous infection]. Probl Tuberk Bolezn Legk (2006) 0.75
[Analyzing the drug resistance of Mycobacterium tuberculosis in Russia's experimental areas introducing the WHO tuberculosis control programme]. Probl Tuberk (2002) 0.75
[Study of the state of parietal microflora and wall of the large intestine of mice under the influence of anomalous magnetic field]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Evaluation of hepatic function in new cases of pulmonary tuberculosis due to the use of standard chemotherapy regimens I and IIB]. Probl Tuberk Bolezn Legk (2009) 0.75
[Advances and perspectives in microbiological diagnosis of tuberculosis]. Probl Tuberk (2001) 0.75
[Implementation of a programme for detection and treatment of patients with tuberculosis in the Vladimir Region]. Probl Tuberk Bolezn Legk (2004) 0.75
[The risk for recurrent pulmonary tuberculosis in dispensary registration group III patients]. Probl Tuberk Bolezn Legk (2007) 0.75
[Study of characteristics of the antigen structure of different mycobacteria (epitope mapping) with monoclonal antibodies]. Biull Eksp Biol Med (1998) 0.75
[Comparison of the stability of morphometric and nonmetric skeletal characteristics of inbred mice with regard to environmental exposure in prenatal development]. Genetika (1988) 0.75
[Antimitotic and cytogenetic activity of small concentrations of carbon disulfide and hydrogen sulfide]. Tsitol Genet (1974) 0.75
[Causes of hemorrhage in the postmenopausal period]. Akush Ginekol (Mosk) (1992) 0.75
[Diagnosis, clinical picture and treatment policy in acute progressive forms of pulmonary tuberculosis under present-day epidemiological conditions]. Probl Tuberk (1999) 0.75
[Monitoring of the detection of new pulmonary tuberculosis cases and the efficiency of their treatment in the area supervised by the Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences]. Probl Tuberk Bolezn Legk (2008) 0.75
[Tinctorial properties of mycobacteria using standard and nontraditional staining technics]. Probl Tuberk (1994) 0.75
[Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria]. Probl Tuberk Bolezn Legk (2004) 0.75
[Use of fluoroquinolones in the intensive phase of treatment of new tuberculosis cases]. Probl Tuberk Bolezn Legk (2008) 0.75
[The role of biofilms in pathogenesis of chronic bacterial rhinosinusitis]. Vestn Otorinolaringol (2014) 0.75
[Microbiological diagnosis of tuberculosis]. Vestn Ross Akad Med Nauk (1995) 0.75
[Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer]. Vopr Onkol (1980) 0.75
[Efficiency of partial pneumonectomies in patients with multidrug-resistant tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.75
[Impact of introduction of the WHO tuberculosis-controlling recommendations adapted to the Russian conditions on the Russian statistical tuberculosis data]. Probl Tuberk Bolezn Legk (2004) 0.75
[Carbohydrate and fat metabolic state in female rats subjected to transplacental diethylstilbestrol exposure]. Akush Ginekol (Mosk) (1981) 0.75
[Transplantation of the cell nuclei of the crystalline lens anlage into mouse zygotes and the expression of alpha-crystallin genes]. Zh Obshch Biol (1988) 0.75